Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» heart failure
heart failure
AstraZeneca, Novoheart to Co-Develop New Heart Model
Xconomy
Wed, 11/27/19 - 10:40 am
AstraZeneca
Novoheart
heart-in-a-jar
heart failure
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
Mon, 11/18/19 - 10:29 am
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
Janssen taps wearable tech in Invokana heart failure trial
Pharmaforum
Mon, 11/18/19 - 10:05 am
JNJ
Janssen
Invokana
heart failure
wearables
real world evidence
clinial trials
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Wed, 11/13/19 - 10:02 am
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
Tue, 11/5/19 - 10:22 am
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
Tue, 10/29/19 - 01:55 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Tue, 10/29/19 - 01:54 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
Mon, 10/21/19 - 10:08 am
AstraZeneca
Farxiga
type 1 diabetes
heart failure
EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure
Fierce Pharma
Thu, 09/19/19 - 07:59 pm
AstraZeneca
Farxiga
EASD
heart failure
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
Mon, 09/16/19 - 09:28 am
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study
Fierce Pharma
Fri, 09/6/19 - 12:38 pm
AstraZeneca
Farxiga
drug reps
heart failure
Heart failure results could unlock key market for Farxiga – AZ
Pharmaforum
Mon, 09/2/19 - 12:22 pm
AstraZeneca
heart failure
diabetes
Farxiga
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
Fierce Pharma
Mon, 09/2/19 - 12:19 pm
Novartis
heart failure
Entresto
clinical trials
ESC
European Society of Cardiology
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
The Hill
Wed, 08/28/19 - 11:00 pm
FDA
heart failure
drug development
Novartis heart drug fails trial, curbing growth prospects
Yahoo/Reuters
Mon, 07/29/19 - 09:26 am
Novartis
heart failure
Entresto
clinical trials
Highlights: 2019 Cardiometabolic Health Congress West
CP Wire
Fri, 05/17/19 - 10:47 am
diabetes
heart disease
cardiometabolic health
heart failure
cardiovascular disease
Highlights: 2019 Cardiometabolic Health Congress West
Fri, 05/17/19 - 10:41 am
diabetes
heart disease
cardiometabolic health
heart failure
ED Drug Shows Promise in Sheep Heart Failure Study
BioSpace
Mon, 05/6/19 - 10:48 am
heart failure
tadalafil
Pfizer
Viagra
Eli Lilly
Cialis
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Fri, 04/19/19 - 10:34 am
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure
Amgen, Servier heart failure drug clears trial hurdle
PM Live
Thu, 03/21/19 - 06:50 pm
Amgen
Servier
heart failure
Omecamtiv Mecarbil
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »